NIH to Launch New On-Line Repository for Life Sciences Research

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 8 No 10
Volume 8
Issue 10

BETHESDA, Md-The new year will bring a new and controversial source for obtaining access to new scientific studies in the life sciences. In January, the National Institutes of Health (NIH) will launch PubMed Central, a free on-line repository of research reports, found at http://www.ncbi.nlm.nih.gov/PubMed/.

BETHESDA, Md—The new year will bring a new and controversial source for obtaining access to new scientific studies in the life sciences. In January, the National Institutes of Health (NIH) will launch PubMed Central, a free on-line repository of research reports, found at http://www.ncbi.nlm.nih.gov/pubmed/.

The site will store, organize, and distribute articles, preprints, and screened reports contributed to the repository by scientific journals and “reputable scientific organizations.” It is unclear, however, to what extent peer-reviewed journals will cooperate with the new venture.

PubMed Central is an expanded form of E-biomed, which NIH director Harold E. Varmus, MD, originally proposed in May as a cyberspace library for the biomedical sciences. His idea drew considerable criticism from companies and organizations that publish scientific journals, which feared the free service would cost them subscribers. The plan was also criticized for the use of materials that were not peer reviewed.

Recent Videos
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content